These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37568209)

  • 41. Neuropsychiatric symptoms and quality of life in Spanish patients with Alzheimer's disease during the COVID-19 lockdown.
    Lara B; Carnes A; Dakterzada F; Benitez I; Piñol-Ripoll G
    Eur J Neurol; 2020 Sep; 27(9):1744-1747. PubMed ID: 32449791
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlates of Conversion from Mild Cognitive Impairment to Dementia with Lewy Bodies: Data from the National Alzheimer's Coordinating Center.
    Payne S; Shofer JB; Shutes-David A; Li G; Jankowski A; Dean P; Tsuang D
    J Alzheimers Dis; 2022; 86(4):1643-1654. PubMed ID: 35213374
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Latent Classes of Neuropsychiatric Symptoms in NACC Controls and Conversion to Mild Cognitive Impairment or Dementia.
    Leoutsakos JM; Forrester SN; Lyketsos CG; Smith GS
    J Alzheimers Dis; 2015; 48(2):483-93. PubMed ID: 26402012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the Neuropsychiatric Inventory Caregiver Distress Scale.
    Kaufer DI; Cummings JL; Christine D; Bray T; Castellon S; Masterman D; MacMillan A; Ketchel P; DeKosky ST
    J Am Geriatr Soc; 1998 Feb; 46(2):210-5. PubMed ID: 9475452
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potentially modifiable factors associated with agitation and aggression in Alzheimer's disease: results of the ICTUS study.
    de Mauleon A; Soto M; Ousset PJ; Nourhashemi F; Lepage B; Vellas B
    Int Psychogeriatr; 2019 Oct; 31(10):1509-1516. PubMed ID: 30714541
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Associations between neuropsychiatric symptoms and incident Alzheimer's dementia in men versus women.
    Liampas I; Siokas V; Lyketsos CG; Dardiotis E
    J Neurol; 2023 Apr; 270(4):2069-2083. PubMed ID: 36572715
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cerebrospinal Fluid Correlates of Neuropsychiatric Symptoms in Patients with Alzheimer's Disease/Mild Cognitive Impairment: A Systematic Review.
    Showraki A; Murari G; Ismail Z; Barfett JJ; Fornazzari L; Munoz DG; Schweizer TA; Fischer CE
    J Alzheimers Dis; 2019; 71(2):477-501. PubMed ID: 31424398
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuropsychiatric symptoms and functional status in Alzheimer's disease and vascular dementia patients.
    D'Onofrio G; Sancarlo D; Panza F; Copetti M; Cascavilla L; Paris F; Seripa D; Matera MG; Solfrizzi V; Pellegrini F; Pilotto A
    Curr Alzheimer Res; 2012 Jul; 9(6):759-71. PubMed ID: 22715983
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuropsychiatric symptoms and Apolipoprotein E: Associations with eventual Alzheimer's disease development.
    Burke SL; Maramaldi P; Cadet T; Kukull W
    Arch Gerontol Geriatr; 2016; 65():231-8. PubMed ID: 27111252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuropsychiatric symptoms in Alzheimer's disease: associations with caregiver burden and treatment outcomes.
    Chen CT; Chang CC; Chang WN; Tsai NW; Huang CC; Chang YT; Wang HC; Kung CT; Su YJ; Lin WC; Cheng BC; Su CM; Hsiao SY; Hsu CW; Lu CH
    QJM; 2017 Sep; 110(9):565-570. PubMed ID: 28383687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Utility of the Neuropsychiatric Inventory Questionnaire (NPI-Q) in the assessment of a sample of patients with Alzheimer's disease in Chile.
    Musa G; Henríquez F; Muñoz-Neira C; Delgado C; Lillo P; Slachevsky A
    Dement Neuropsychol; 2017; 11(2):129-136. PubMed ID: 29213504
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association Between Neuropsychiatric Symptom Trajectory and Conversion to Alzheimer Disease.
    Lo TWB; Karameh WK; Barfett JJ; Fornazzari LR; Munoz DG; Schweizer TA; Fischer CE;
    Alzheimer Dis Assoc Disord; 2020; 34(2):141-147. PubMed ID: 31633557
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Longitudinal Course of Agitation and Aggression in Patients with Alzheimer's Disease in a Cohort Study: Methods, Baseline and Longitudinal Results of the A3C Study.
    De Mauleon A; Delrieu J; Cantet C; Vellas B; Andrieu S; Rosenberg PB; Lyketsos CG; Soto Martin M
    J Prev Alzheimers Dis; 2021; 8(2):199-209. PubMed ID: 33569568
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Most families tend to realize progress of Alzheimer's disease when behavioural and psychological symptoms are obvious.
    Honjo Y; Ide K; Takechi H
    Psychogeriatrics; 2022 May; 22(3):317-323. PubMed ID: 35146847
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patterns of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Risk of Dementia.
    Forrester SN; Gallo JJ; Smith GS; Leoutsakos JM
    Am J Geriatr Psychiatry; 2016 Feb; 24(2):117-25. PubMed ID: 26209222
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Associations of Frailty with Neuropsychiatric Symptoms of Alzheimer's Disease: A Longitudinal Study.
    Chi HC; Ma LZ; Wang ZB; Sheng ZH; Liu JY; Mi YC; Fu Y; Huang YM; Han SL; Gao PY; ; Tan L; Yu JT
    J Alzheimers Dis; 2024; 98(2):629-642. PubMed ID: 38427482
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Participant-Informant Relationships Affect Quality of Life Ratings in Incipient and Clinical Alzheimer Disease.
    Lin A; Brook J; Grill JD; Teng E
    Am J Geriatr Psychiatry; 2017 Mar; 25(3):297-307. PubMed ID: 27818119
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuropsychiatric symptoms in MCI subtypes: the importance of executive dysfunction.
    Rosenberg PB; Mielke MM; Appleby B; Oh E; Leoutsakos JM; Lyketsos CG
    Int J Geriatr Psychiatry; 2011 Apr; 26(4):364-72. PubMed ID: 20845402
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessing the Stability of Clusters of Neuropsychiatric Symptoms in Alzheimer's Disease and Mild Cognitive Impairment.
    Scarfo S; Moshfeghi Y; J McGeown W
    Curr Alzheimer Res; 2024 Jul; ():. PubMed ID: 39021180
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mild cognitive impairment is associated with characteristic neuropsychiatric symptoms.
    Hwang TJ; Masterman DL; Ortiz F; Fairbanks LA; Cummings JL
    Alzheimer Dis Assoc Disord; 2004; 18(1):17-21. PubMed ID: 15195459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.